Weight loss brings health benefits at any age, but is difficult for many to achieve and sustain.
In every news cycle, there’s at least one story about GLP-1 drugs such as Ozempic, Wegovy and Zepbound. Although some extol the drugs’ health benefits, most focus on economics, including the drugs’ high cost, the growing reluctance of private and public insurance plans to cover the expense and the resulting affordability crisis for patients. With a dose of common sense, we can solve…
Continue Reading
News Source: www.forbes.com

Leave a Reply